AI in Prior Authorization: What Payers Need to Know
AI is reshaping how payers think about prior authorization, and the vendor landscape is moving fast. But speed and capability in a demo are not the same as consistency and defensibility in production. This guide examines where AI delivers real value in prior authorization, where it introduces risk, and what a governed, policy-driven model actually requires.
The Question Is Not Whether to Use AI
Artificial intelligence is rapidly reshaping how payers approach prior authorization. Vendors increasingly position AI as a solution capable of interpreting medical policies, generating structured artifacts such as FHIR Questionnaires, and automating clinical decisions. In demonstrations, this appears compelling: narrative policy documents are converted into structured outputs, workflows are accelerated, and automation seems within reach.
The central question for payers is whether AI, operating on its own, can perform consistently, compliantly, and at scale in a regulated environment where every decision must be clinically accurate and explainable. When AI and structured, clinically governed policy operate together within clearly defined guardrails, prior authorization becomes consistent, compliant, auditable, and scalable. Neither alone is sufficient.
Prior authorization is a policy execution function, and that framing changes everything about how AI should be evaluated and applied.
Prior Authorization Is Policy Execution
What drives prior authorization is the consistent and accurate application of medical policy, not workflow speed, automation volume, or decision turnaround time.
Medical policy carries more weight than documentation alone. For payers, it serves as:
- A clinical framework defining medical necessity
- A contractual artifact governing coverage obligations
- A legal construct subject to audit and dispute
Every prior authorization decision must therefore be:
- Deterministic: the same inputs produce the same outcome
- Traceable: tied to a specific policy and version
- Explainable: clearly linked to clinical criteria
- Auditable: defensible under regulatory review
Without policy represented in a structured, computable format, systems cannot reliably determine which criteria apply, how those criteria should be evaluated, or how decisions should be executed.
Where AI Delivers Real Value
AI is already delivering meaningful value in prior authorization, primarily in areas where the challenge is organizing and surfacing information rather than defining or executing policy.
The most effective applications today include:
- Extracting relevant clinical data from unstructured documentation
- Summarizing patient histories to support faster review
- Identifying missing or incomplete information before submission
- Providing clinical reviewers with contextual insights
In these use cases, AI reduces manual effort and improves operational efficiency without altering the underlying decision framework. The implication is clear: AI is most effective when it supports decision-making rather than replacing it.
Where AI Falls Short: Interpretation vs. Execution
The limitations of AI in prior authorization stem from a fundamental mismatch between what AI is designed to do and what prior authorization requires.
Most AI solutions rely on general-purpose language models designed to interpret and generate text rather than execute deterministic clinical logic. Even when fine-tuned or provided with additional context, they remain probabilistic systems. When applied to medical policy, this creates a critical issue: AI reinterprets policy rather than encoding it.
This leads to several risks for payers:
- Variability in outputs, even with similar inputs
- Loss of clinical nuance, especially in exceptions and edge cases
- Inconsistent policy representations across systems and workflows
- Limited explainability of how decisions were derived
From a clinical perspective, this undermines confidence in how policy is applied. From a compliance perspective, it introduces real exposure in audits, disputes, and regulatory reviews.
The Risk of “Shadow Policy”
One of the most significant, and often overlooked, risks of AI-driven approaches is what can be described as a “shadow policy.”
When AI converts narrative policy into structured artifacts such as questionnaires or decision logic, it generates a new representation of the policy rather than simply encoding it. Over time, this can produce:
- Multiple versions of policy distributed across systems
- Divergence between written policy and executed logic
- Difficulty determining which version is authoritative
- Increased exposure in audits, disputes, and compliance reviews
The system ends up executing an AI-generated interpretation of policy rather than the policy itself. For payer organizations with established governance processes and clinical accountability frameworks, this represents a significant and often underestimated risk.
A System That Moves Faster Is Not Necessarily One That Works Better
Emerging industry evidence highlights an important dynamic that payers should weigh carefully. While AI can reduce manual effort at the task level, it does not necessarily reduce system-wide cost or complexity.
Emerging industry analysis, including research published by the Peterson Health Technology Institute, suggests that while AI can reduce manual effort in prior authorization workflows, it may also increase overall system activity and costs without addressing underlying inefficiencies.
In practice, payers and their partners are observing:
- Increased transaction volumes as both sides of the exchange adopt AI tooling
- More frequent back-and-forth interactions between systems
- Limited impact on complex cases, where judgment still drives outcomes
- Rising overall system activity with diminishing per-interaction returns
As both providers and payers adopt AI, interactions can escalate into what some describe as “automation loops,” bot-driven exchanges that move quickly but accomplish little. The result is a system that moves faster without necessarily working better. Optimizing individual steps does not resolve systemic inefficiencies.
Clinical Oversight Cannot Be Delegated to a Model
Regardless of how capable AI becomes, clinical accountability cannot be delegated to a model. Payer clinical teams remain responsible for:
- Defining and maintaining medical policy
- Ensuring clinical appropriateness of coverage decisions
- Reviewing and validating outputs before they affect members
- Maintaining consistency across cases and contexts
Even in AI-assisted environments, clinicians must review outputs. AI introduces a new challenge here: when outputs are incorrect or inconsistent, it is often difficult to determine why. Responses such as “the model was re-prompted” do not provide the level of transparency required in a clinical or regulatory context.
This lack of explainability becomes particularly problematic when AI is used to interpret policy, generate decision logic, or automatically approve or deny requests.
A Better Model: AI With Guardrails
The most effective approach to prior authorization for payers is a governed system in which AI operates within clearly defined boundaries, rather than an AI-driven model or a policy-only one. This model includes three essential components:
- Structured, Clinically Governed Policy. Policy is authored and maintained by clinical teams in a structured, computable format that serves as the single source of truth for all downstream processes.
- Deterministic Applicability and Decisioning. Systems explicitly determine which policy applies to a given request and execute criteria in a consistent, reproducible manner, regardless of volume or clinical complexity.
- AI as an Assistive Layer. AI enhances data extraction, summarization, and workflow efficiency, but does not define policy, determine applicability, or drive final decisions.
Together, these components ensure that AI improves efficiency without compromising consistency, transparency, or control.
Questions Payers Should Be Asking
Health plans evaluating AI-driven prior authorization solutions should look beyond demonstrations and assess whether vendors can support a governed, policy-driven system. Key questions include:
Policy and Governance
- What is the system of record for medical policy, and how is it maintained?
- How are policies structured, versioned, and approved by clinical teams?
- How is drift between written policy and executed system logic detected and corrected?
Applicability and Decisioning
- How is policy applicability determined across lines of business, groups, programs, and procedure codes?
- Are decisions deterministic and reproducible across identical inputs?
- Can every decision be traced back to a specific policy and criteria set?
AI Role and Risk
- Is AI assistive, or is it making decisions autonomously?
- How are inconsistencies in AI output identified and resolved?
- What governs AI behavior in edge cases or scenarios with incomplete data?
Regulatory Readiness
- Are FHIR Questionnaires generated deterministically from governed policy?
- Are CRD, DTR, and PAS responses consistent and traceable to policy?
- How is compliance with CMS-0057-F requirements validated and sustained over time?
Clear, precise answers to these questions are often a stronger indicator of actual capability than any product demonstration.
Building on the Right Foundation
The future of prior authorization will be defined by how effectively payer organizations integrate AI and policy into a governed system where each component performs the role it is best suited for, rather than by either AI or policy working in isolation.
Health plans that answer the right questions and select partners who can support a structured, deterministic, policy-driven model will not only meet CMS-0057-F requirements. They will establish a scalable, defensible foundation for prior authorization that performs consistently as volumes grow, regulations evolve, and AI capabilities continue to advance.
This is the first article in a three-part series on modernizing prior authorization. Part 2 explores the core capabilities required for a governed, policy-driven PA system. Part 3 details how Itiliti Health operationalizes these capabilities.